Article Details

Sanofi to acquire UK biotechnology firm Vicebio for up to $1.6bn

Retrieved on: 2025-07-23 14:23:22

Tags for this article:

Click the tags to see associated articles and topics

Sanofi to acquire UK biotechnology firm Vicebio for up to $1.6bn. View article details on hiswai:

Excerpt

The 'Molecular Clamp' technology stabilises viral proteins in their native form, allowing the immune system to recognise and respond more effectively.

Article found on: www.worldpharmaceuticals.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo